Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe

Jauregui, 2011, Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: Lessons learned by PAHO's ProVac Initiative, Vaccine, 29, 1099, 10.1016/j.vaccine.2010.11.075 Jauregui, 2015, Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience, Vaccine, 33, A28, 10.1016/j.vaccine.2014.10.090 Clark, 2013, TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilusinfluenzae type b, pneumococcal and rotavirus vaccination, Vaccine, 31, C19, 10.1016/j.vaccine.2013.05.045 Komakhidze, 2015, Cost-effectiveness analysis: Introduction of the pneumococcal conjugate vaccine (PCV) in Georgia. Strengthening national decision-making processes for immunization through capacity-building on economic evaluation: implementing ProVac tools in Europe, Vaccine, 33, A219, 10.1016/j.vaccine.2014.12.070 Ahmeti A, 2015, Cost-effectiveness of rotavirus vaccination in Albania. Strengthening national decision-making processes for immunization through capacity-building on economic evaluation: implementing ProVac tools in Europe, Vaccine, 33, A201 Višekruna Vučina, 2015, Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Strengthening national decision-making processes for immunization through capacity-building on economic evaluation: implementing ProVac tools in Europe, Vaccine, 33, A209